OncoQuest Pharmaceuticals Inc (078590) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OncoQuest Pharmaceuticals Inc (078590) has a cash flow conversion efficiency ratio of -0.019x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.42 Billion ≈ $-964.13K USD) by net assets (₩74.92 Billion ≈ $50.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OncoQuest Pharmaceuticals Inc net asset quality index to measure how much of total assets are equity-financed.
OncoQuest Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how OncoQuest Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of OncoQuest Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
OncoQuest Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OncoQuest Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Emporiki Eisagogiki Aftokiniton Ditrohon kai Mihanon Thalassis Societe Anonyme
AT:MOTO
|
-0.109x |
|
TPL Plastech Limited
NSE:TPLPLASTEH
|
0.277x |
|
Marchex Inc
NASDAQ:MCHX
|
0.004x |
|
DocCheck AG
XETRA:AJ91
|
0.043x |
|
Johnson Chemical Pharmaceutical Works Co Ltd
TWO:4747
|
0.012x |
|
Next Technology Holding Inc
NASDAQ:NXTT
|
-0.003x |
|
Hwa Sung Ind
KO:002460
|
-0.092x |
|
Vitura S.A.
PA:VTR
|
-0.013x |
Annual Cash Flow Conversion Efficiency for OncoQuest Pharmaceuticals Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of OncoQuest Pharmaceuticals Inc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see 078590 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩48.94 Billion ≈ $33.17 Million |
₩485.35 Million ≈ $328.91K |
0.010x | -88.00% |
| 2024-12-31 | ₩47.92 Billion ≈ $32.47 Million |
₩3.96 Billion ≈ $2.68 Million |
0.083x | -67.92% |
| 2023-12-31 | ₩43.42 Billion ≈ $29.43 Million |
₩11.19 Billion ≈ $7.58 Million |
0.258x | +3873.45% |
| 2022-12-31 | ₩34.70 Billion ≈ $23.51 Million |
₩-236.91 Million ≈ $-160.55K |
-0.007x | +96.04% |
| 2019-12-31 | ₩24.71 Billion ≈ $16.74 Million |
₩-4.26 Billion ≈ $-2.89 Million |
-0.172x | -413.09% |
| 2018-12-31 | ₩26.14 Billion ≈ $17.71 Million |
₩1.44 Billion ≈ $975.22K |
0.055x | -80.11% |
| 2017-12-31 | ₩17.32 Billion ≈ $11.73 Million |
₩4.79 Billion ≈ $3.25 Million |
0.277x | +11.73% |
| 2016-12-31 | ₩14.30 Billion ≈ $9.69 Million |
₩3.54 Billion ≈ $2.40 Million |
0.248x | +6.21% |
| 2015-12-31 | ₩11.98 Billion ≈ $8.12 Million |
₩2.79 Billion ≈ $1.89 Million |
0.233x | +63.10% |
| 2014-12-31 | ₩7.10 Billion ≈ $4.81 Million |
₩1.02 Billion ≈ $688.18K |
0.143x | -- |
About OncoQuest Pharmaceuticals Inc
DIAC Co., Ltd. engages in the car interior and exterior materials business in South Korea and internationally. DIAC Co., Ltd. was founded in 1993 and is headquartered in Miryang-si, South Korea.